<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00190476</url>
  </required_header>
  <id_info>
    <org_study_id>JCOG0207</org_study_id>
    <secondary_id>C000000146</secondary_id>
    <nct_id>NCT00190476</nct_id>
  </id_info>
  <brief_title>Elderly NSCLC/D vs DP (JCOG0207)</brief_title>
  <official_title>Randomized Controlled Trial Comparing Docetaxel-cisplatin Combination With Docetaxel Alone in Elderly Patients With Advanced Non-small-cell Lung Cancer(JCOG0207)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Japan Clinical Oncology Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, Labour and Welfare, Japan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Japan Clinical Oncology Group</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the efficacy of docetaxel-cisplatin combination in comparison to docetaxel alone
      for elderly patients with advanced non-small-cell lung cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Elderly Lung Cancer Vinorelbine Italian Study demonstrated the first evidence of the
      utility of chemotherapy in elderly patients with advanced non-small-cell lung cancer (NSCLC).
      In a large randomized trial, gemcitabine and vinorelbine failed to show any advantage over
      either agent alone. With the current evidence, single agent chemotherapy with a
      third-generation drug can be considered a recommended option for elderly patients with
      advanced NSCLC. A Japanese phase I/II study showed the activity (overall response rate 52%,
      median survival 12.4 months) and tolerability of weekly docetaxel/ cisplatin combination in
      patients older than age 75 years. There have been no randomized prospective trials dedicated
      to elderly NSCLC patients to evaluate tolerability and efficacy of platinum-based
      combination.

      Comparison: Single-agent weekly docetaxel versus weekly regimen of docetaxel-cisplatin
      combination for elderly advanced NSCLC.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date>April 2003</start_date>
  <completion_date>April 2007</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>overall survival</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Toxicity</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Progression-free survival</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Response rate</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symptom score</measure>
  </secondary_outcome>
  <enrollment>230</enrollment>
  <condition>Non-small-cell Lung Cancer</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Weekly docetaxel alone</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Weekly docetaxel + cisplatin combination</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. histologically or cytologically proven non-small-cell lung cancer

          2. stage IV, or stage III disease ineligible for definitive radiotherapy

          3. 70 years or older

          4. ECOG PS 0-1

          5. Ineligible for standard platinum(bolus infusion)-containing combination chemotherapy

          6. No prior chemotherapy(containing gefitinib) for non-small cell lung cancer or other
             neoplasms

          7. No prior surgery within 4 weeks before enrollment

          8. No prior radiotherapy for primary tumor

          9. No prior radiotherapy for metastatic lesions within 2 weeks before enrollment

         10. Adequate organ function

         11. Signed informed consent

        Exclusion Criteria:

          1. Symptomatic brain metastasis

          2. Active another neoplasms

          3. Severe SVC syndrome

          4. Massive pericardial, pleural effusion, or ascites

          5. Bone metastasis emergent for palliative radiotherapy or surgery

          6. Uncontrollable systemic hypertension

          7. Heart failure, Unstable angina, Myocardial infarction within 6 months

          8. Uncontrollable diabetes

          9. Active infection

         10. Interstitial pneumonia/ Pulmonary fibrosis

         11. Hypersensitivity for polysorbate 80

         12. Systemic administration of corticosteroids
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Akira Yokoyama, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Internal Medicine, Niigata Cancer Center Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aichi Cancer Center Hospital</name>
      <address>
        <city>Nagoya,Chikusa-ku,Kanokoden,1-1</city>
        <state>Aichi</state>
        <zip>464-8681</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aichi Cancer Center,Aichi Hospital</name>
      <address>
        <city>Okazaki,Kake-machi,Kuriyado,18</city>
        <state>Aichi</state>
        <zip>444-0011</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Cancer Center Hospital East</name>
      <address>
        <city>Kashiwa,Kashiwanoha,6-5-1</city>
        <state>Chiba</state>
        <zip>277-8577</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Hospital Organization Shikoku Cancer Center</name>
      <address>
        <city>Matsuyama,Horinouchi,13</city>
        <state>Ehime</state>
        <zip>790-0007</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kyushu University Hospital</name>
      <address>
        <city>Higashi-ku,Maidashi,3-1-1</city>
        <state>Fukuoka</state>
        <zip>812-8582</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gifu Municipal Hospital</name>
      <address>
        <city>Gifu,Kashima-cho,7-1</city>
        <state>Gifu</state>
        <zip>500-8323</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gunma Prefectural Cancer Center</name>
      <address>
        <city>Ota,Takabayashi-nishi-cho,617-1</city>
        <state>Gunma</state>
        <zip>373-8550</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Nishigunma Hospital</name>
      <address>
        <city>Shibukawa,Kanai,2854</city>
        <state>Gunma</state>
        <zip>377-8511</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Hospital Organization, Dohoku National Hospital</name>
      <address>
        <city>Asahikawa,Hanasaki,7-4048</city>
        <state>Hokkaido</state>
        <zip>070-8644</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Hospital Organization Hokkaido Cancer Center</name>
      <address>
        <city>Sapporo,Shiroishi-ku,Kikusui,4-2-3-54</city>
        <state>Hokkaido</state>
        <zip>003-0804</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hyogo Medical Center for Adults</name>
      <address>
        <city>Akashi,Kitaouji-cho,13-70</city>
        <state>Hyogo</state>
        <zip>673-8558</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hyogo College of Medicine</name>
      <address>
        <city>Nishinomiya,Mukogawa-cho,1-1</city>
        <state>Hyogo</state>
        <zip>663-8501</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ibaraki Kenritsu Chuo Hospital &amp; Cancer Center</name>
      <address>
        <city>Nishi-ibarakigun,Tomobemachi,Koibuchi,6528</city>
        <state>Ibaraki</state>
        <zip>309-1793</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kanagawa Cancer Center</name>
      <address>
        <city>Yokohama,Asahi-ku,Nakao,1-1-2</city>
        <state>Kanagawa</state>
        <zip>241-0815</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yokohama Mucipical Citizen's Hospital</name>
      <address>
        <city>Yokohama,Hodogaya-ku,Okazawa-cho,56</city>
        <state>Kanagawa</state>
        <zip>240-8555</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kumamoto Regional Medical Center Hospital</name>
      <address>
        <city>Kumamoto,Honjo,5-16-10</city>
        <state>Kumamoto</state>
        <zip>860-0811</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Niigata Cancer Center Hospital</name>
      <address>
        <city>Niigata,Kawagishi-cho, 2-15-3</city>
        <state>Niigata</state>
        <zip>951-8566</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Osaka Prefectural Medical Center for Respiratory and Allergic Disease</name>
      <address>
        <city>Habikino,Habikino,3-7-1</city>
        <state>Osaka</state>
        <zip>583-8588</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Osaka Medical Center for Cancer and Cardiovascular Diseases</name>
      <address>
        <city>Osaka,Higashinari-ku,Nakamichi,1-3-3</city>
        <state>Osaka</state>
        <zip>537-8511</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Osaka City General Hospital</name>
      <address>
        <city>Osaka,Miyakojima-ku,Miyakojimahondori,2-13-22</city>
        <state>Osaka</state>
        <zip>534-0021</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kinki University School of Medicine</name>
      <address>
        <city>Osaka-Sayama,Ohno-higashi,377-2</city>
        <state>Osaka</state>
        <zip>589-8511</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Hospital Organization Kinki-Chuo Chest Medical Center</name>
      <address>
        <city>Sakai,Nagasone,1180</city>
        <state>Osaka</state>
        <zip>591-8555</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Hospital Organization Toneyama National Hospital</name>
      <address>
        <city>Toyonaka,Toneyama,5-1-1</city>
        <state>Osaka</state>
        <zip>560-8552</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saitama Cancer Center</name>
      <address>
        <city>Kita-adachi,Ina,Komuro,818</city>
        <state>Saitama</state>
        <zip>362-0806</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sizuoka Cancer Center</name>
      <address>
        <city>Sunto-gun,Nagaizumi-cho,Shimonagakubo,1007</city>
        <state>Shizuoka</state>
        <zip>411-8777</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tochigi Cancer Center</name>
      <address>
        <city>Utsunomiya,Yohnan,4-9-13</city>
        <state>Tochigi</state>
        <zip>320-0834</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Cancer Center Hospital</name>
      <address>
        <city>Chuo-ku,Tsukiji,5-1-1</city>
        <state>Tokyo</state>
        <zip>104-0045</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>International Medical Center of Japan</name>
      <address>
        <city>Shinjuku-ku,Toyama,1-21-1</city>
        <state>Tokyo</state>
        <zip>162-8655</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yamagata Prefectural Central Hospital</name>
      <address>
        <city>Yamagata,Aoyagi,1800</city>
        <state>Yamagata</state>
        <zip>990-2292</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <link>
    <url>http://www.jcog.jp/</url>
  </link>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 11, 2005</study_first_submitted>
  <study_first_submitted_qc>September 11, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 19, 2005</study_first_posted>
  <last_update_submitted>September 8, 2016</last_update_submitted>
  <last_update_submitted_qc>September 8, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 12, 2016</last_update_posted>
  <keyword>Elderly</keyword>
  <keyword>advanced</keyword>
  <keyword>non-small-cell lung cancer</keyword>
  <keyword>cisplatin</keyword>
  <keyword>docetaxel</keyword>
  <keyword>weekly</keyword>
  <keyword>combination</keyword>
  <keyword>chemotherapy</keyword>
  <keyword>randomized trial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Docetaxel</mesh_term>
    <mesh_term>Cisplatin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

